Like everything created through legislation, House Bill 8 was a product of politics and carries echoes of that oppositional ...

Sangamo Therapeutics, Inc.’s (NASDAQ:SGMO) share price has underperformed over the past year, down nearly 64%.

House Bill 8 replaces the once-a-year State of Texas Academic Assessment of Readiness with tests at the beginning, middle and ...

Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now ...

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

CREEED’s Education for All Initiative honors teachers at five elementary schools in El Paso County with a large number of ...

One semester in, three North Austin middle schools give insights into lessons for other campuses planning turnarounds.

Staar Surgical, a manufacturer of the Implantable Collamer Lens, has delayed a shareholder vote on Alcon’s planned $1.6 billion takeover offer for the fourth time since October. In October, the vote ...

STAAR Surgical (STAA) said it received no takeover offers during its go-shop period that expired on Saturday. STAAR (STAA) said 21 parties were contacted during its go-shop period, through none of the ...

In August, Geneva, Switzerland-based eye care company Alcon agreed to buy Staar Surgical in a deal valued at $1.5 billion, but STAAR has faced opposition to the deal, including from its largest ...

Oct 22 (Reuters) - Medtech firm Staar Surgical's (STAA.O), opens new tab biggest investor, Broadwood Partners, is planning to call a shareholder meeting to remove several directors, it said on ...

STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following ...